WATCH: ‘Ozempic face?’ Dr. Siegel warns of popular diabetes drug’s bizarre side effect

Sign up for DML's newsletter

If you paid for a TeamDML Membership and would like to see every article, and see them without the ads, please click here. If you are NOT a member, or if your Membership has expired, and you would like to join TeamDML please click here.

As the most reliable and balanced news aggregation service on the internet, DML News App offers the following information published by Fox News:

It’s the weight loss drug people have dreamed of  – or is it?

Diabetes drugs like semaglutide and tirzepatide have taken the medical community by storm, helping to not only keep certain endocrine disorders at bay, but also by showing promising signs of appetite control, improved insulin sensitivity, and, with both, weight loss. But the miraculous effects of the TikTok-famous Ozempic injections come at a cost.

“I spoke with some dermatologists about this yesterday,” Dr. Siegel said of “Ozempic face,” a bizarre side effect reported in Ozempic patients who claim the drug is making them look older. “It’s an overuse of the drug to where you lose weight too quickly. The buccal mucosa – the fat – leaves your face, and you become gaunt looking.”

On Fox & Friends Weekend, Siegel warned that the side effect could possibly be irreversible, including sagging skin, an older appearance, and a “gaunt face.”

“It’s something that happens to us anyway as we get older,” he said.

Despite the insanely popular “weight loss” injections’ side effect, Dr. Siegel praised the drug.

“Ozempic is actually a great drug. It’s the first weight loss drug I’ve seen that I think really works. It actually improves insulin, it improves getting rid of sugar, it decreases hunger,” he explained.

The drug became popularized on TikTok because of its weight loss benefits, which has created shortages and sparked the debate surrounding whether patients should have off-label access to the drug.

Wegovy, another strong semaglutide injection and glucagon-like peptide agonist (GLP-1 agonist), was approved by the FDA since Ozempic’s spike in popularity.

Experts have also warned that the drug can cause vision changes, rare forms of thyroid tumors, gallbladder issues, and kidney problems.


To get more information about this article, please visit Fox News.

The Dennis Michael Lynch Podcast is available below. Never miss an episode. Subscribe to the show by downloading The DML News App or go to Apple Podcasts.